| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.089 | 0.6 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.097 | 0.6 |